Six years of qualification
Audited Supplier
In This Store
Chiral Quest was founded in 2000, we provide chemical development and contract manufacturing services to meet demand at all stages of chemical development(kilo-lab, pilot-plant and commercial scale manufacture).
Chiral Quest has a manufacturing site in Jiangxi province (www.cqlonglife.cn), headquarters and R&D centre located in Suzhou Industrial Park; and three overseas offices located in USA, Europe and India. We have expertise in asymmetric hydrogenation, multi-step synthesis and cryogenic reactions. With 5 granted U.S. patents for asymmetric hydrogenation catalysts and 6 process patents for innovative routes to generic API intermediates.
Year of Establishment: 2000
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 10-50
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Quality Service
Other Competitive Advantages: CMO Chiral Quest serves the global pharmaceutical industry with custom contract chemical development and manufacturing services, from preclinical development to commercial supply. We have a state-of-the-art R&D laboratory, equipped with modern analytical instruments, as well as a first class manufacturing facility. Chiral Quest has successfully developed more than 400 intermediates for Active Pharmaceutical Ingredients. Ranging from preclinical to phase III, with four intermediates being supplied for API’s approved by the FDA.We manufacture technology advantaged products from grams to metric ton scale. Generic Drug Intermediates Chiral Quest’s key technologies for asymmetric hydrogenation have been applied to innovative routes for the manufacture of generic drugs intermediates, on metric ton scale. For example, intermediates for Sitagliptin, Duloxetine, Aprepitant, Sacubitril and Lifesistat.
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
